Biotek-snakken — Oktober 2021
-
Ja, Rasbom…MLEX (Bank of America) og MSE (Morgan Stanley) bestemmer fuldstændig kursudviklingen….uanset hvad var det et underligt fald igår og her til morgen. Kursen blev presset helt ned i 18, før de 2 førnævnte begyndte at samle op, og nu er kursen tilbage omkring 19?? Som om de lige
prøver at ryste træet?? -
Can This COVID Vaccine Stock Help Make You Rich? https://www.proinvestor.com/investornyt/719038/can-this-covid-vaccine-stock-help-make-you-rich
-
FDA Approves Roche's Tecentriq As Adjuvant Treatment For Early Non-small Cell Lung Cancer https://www.proinvestor.com/investornyt/719016/fda-approves-roches-tecentriq-as-adjuvant-treatment-for-early-non-small-cell-lung-cancer
-
Will AstraZeneca Have a Big Market for Its COVID-19 Therapy? https://www.proinvestor.com/investornyt/718997/will-astrazeneca-have-a-big-market-for-its-covid-19-therapy
-
Chr. Hansen- Studie; BB-12
til børn med colic https://www.proinvestor.com/index.php?p=debat_1&postid=97917 -
Pfizer og Moderna venter en fordobling af vaccinesalg i 2022
https://www.proinvestor.com/investornyt/719211/pfizer-og-moderna-venter-en-fordobling-af-vaccinesalg-i-2022 -
2 Biotech Stocks Set to Go Supernova Soon https://www.proinvestor.com/investornyt/719296/2-biotech-stocks-set-to-go-supernova-soon
-
Is Moderna a Good Healthcare Stock to Buy Now? https://www.proinvestor.com/investornyt/719337/is-moderna-a-good-healthcare-stock-to-buy-now
-
These 2 Nasdaq Biotechs Are Making Huge Premarket Moves Monday
https://www.proinvestor.com/investornyt/719336/these-2-nasdaq-biotechs-are-making-huge-premarket-moves-monday -
Radius Reports Positive Phase 3 Results For TYMLOS Subcutaneous Injection In Males With Osteoporosis https://www.proinvestor.com/investornyt/719346/radius-reports-positive-phase-3-results-for-tymlos-subcutaneous-injection-in-males-with-osteoporosis
-
Entasis: så kom der positive ph3 data på SUL-DUR, endpoints met. Conf call Oct 19 8:00am ET https://www.globenewswire.com/news-release/2021/10/18/2316018/0/en/Entasis-Therapeutics-announces-positive-topline-results-for-sulbactam-durlobactam-SUL-DUR-from-Phase-3-ATTACK-trial.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind